HLA-G is a molecule that was first known to confer protection to the fetus from destruction by
the immune system of its mother, thus critically contributing to fetal–maternal tolerance. The …

The genetic factors associated with susceptibility or resistance to viral infections are likely to
involve a sophisticated array of immune response. These genetic elements may modulate …

The ongoing COVID-19 pandemic has caught the attention of the global community and
rekindled the debate about our ability to prevent and manage outbreaks, epidemics, and …

Human leukocyte antigen G (HLA-G) belongs to the family of non-classical HLA class I
genes, located within the major histocompatibility complex (MHC). HLA-G has been the …

HLA‐G immune modulatory genes and molecules are presently being studied by a
widespread number of research groups. In the present study, we do not aim to be exhaustive …

Human leukocyte antigen (HLA)-G molecule, a non-classical HLA-Ib molecule, is less
polymorphic when compared to classical HLA class I molecules. Human leukocyte antigen …

We here review the current data on the role of HLA‐G in cancer based on recent findings of
an unexpected antitumor activity of HLA‐G in hematological malignancies. For the past …

HLA‐G is a nonclassical major histocompatibility complex molecule first described at the
maternal‐fetal interface, on extravillous cytotrophoblasts. Its expression is restricted to some …

Considering that the non-classical HLA-G molecule has well-recognized tolerogenic
properties, HLA-G expression is expected to be deleterious when present in tumor cells and …

While persistent infection with oncogenic types of human Papillomavirus (HPV) is required
for cervical epithelial cell transformation and cervical carcinogenesis, HPV infection alone is …